Literature DB >> 23042034

Spastic cocontraction in hemiparesis: effects of botulinum toxin.

Maria Vinti1, Filomena Costantino, Nicolas Bayle, David M Simpson, Donald J Weisz, Jean-Michel Gracies.   

Abstract

INTRODUCTION: In this study of spastic hemiparesis we evaluated cocontraction during sustained agonist/antagonist efforts, before and after botulinum toxin (BoNT) injection in 1 agonist.
METHODS: Nineteen hemiparetic subjects performed maximal isometric elbow flexion/extension efforts with the elbow at 100° (extensors stretched). Using flexor and extensor surface electromyography we calculated agonist recruitment/cocontraction indices from 500-ms peak voluntary agonist recruitment, before and 1 month after onabotulinumtoxinA injection (160 U) into biceps brachii.
RESULTS: Before injection, agonist recruitment and cocontraction indices were higher in extensors than flexors [0.74 ± 0.15 vs. 0.59 ± 0.10 (P < 0.01) and 0.43 ± 0.25 vs. 0.25 ± 0.13 (P < 0.05), respectively]. Biceps injection decreased extensor cocontraction index (-35%, P < 0.05) while increasing flexor agonist recruitment and cocontraction indices.
CONCLUSIONS: In spastic hemiparesis, stretch may facilitate agonist recruitment and spastic cocontraction. In the non-injected antagonist, cocontraction may be reduced by enhanced reciprocal inhibition from a more relaxed, and therefore stretched, agonist, or through decreased recurrent inhibition from the injected muscle.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042034     DOI: 10.1002/mus.23427

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.

Authors:  Matteo Caleo; Matteo Spinelli; Francesca Colosimo; Ivica Matak; Ornella Rossetto; Zdravko Lackovic; Laura Restani
Journal:  J Neurosci       Date:  2018-10-12       Impact factor: 6.167

2.  Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.

Authors:  Jean-Michel Gracies; Gerard E Francisco; Robert Jech; Svetlana Khatkova; Carl D Rios; Pascal Maisonobe
Journal:  J Neurol Phys Ther       Date:  2021-07-01       Impact factor: 3.649

3.  Spinal plasticity in stroke patients after botulinum neurotoxin A injection in ankle plantar flexors.

Authors:  Claire Aymard; Louis-Solal Giboin; Alexandra Lackmy-Vallée; Véronique Marchand-Pauvert
Journal:  Physiol Rep       Date:  2013-11-26

4.  New Injection Points of Onabotulinum Toxin A for Spastic Paralysis of the Fingers: Eight Cases of Report.

Authors:  Shoko Merrit Yamada; Shinnosuke Takashima; Yoshiro Takaoka; Hiroshi Matsuura
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

5.  Precise quantification of the time course of voluntary activation capacity following Botulinum toxin injections in the biceps brachii muscles of chronic stroke survivors.

Authors:  S Chandra; B Afsharipour; W Z Rymer; N L Suresh
Journal:  J Neuroeng Rehabil       Date:  2020-07-23       Impact factor: 4.262

Review 6.  Central Effects of Botulinum Neurotoxin-Evidence from Human Studies.

Authors:  David Weise; Christopher M Weise; Markus Naumann
Journal:  Toxins (Basel)       Date:  2019-01-06       Impact factor: 4.546

7.  Characteristic Variation of Electromechanical Delay After the Botulinum Toxin Injection in Spastic Biceps Brachii Muscles.

Authors:  Sourav Chandra; Babak Afsharipour; William Z Rymer; Nina L Suresh
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.003

8.  Lasting Peripheral and Central Effects of Botulinum Toxin Type A on Experimental Muscle Hypertonia in Rats.

Authors:  Petra Šoštarić; Barbara Vukić; Lea Tomašić; Ivica Matak
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

Review 9.  Combining Upper Limb Robotic Rehabilitation with Other Therapeutic Approaches after Stroke: Current Status, Rationale, and Challenges.

Authors:  Stefano Mazzoleni; Christophe Duret; Anne Gaëlle Grosmaire; Elena Battini
Journal:  Biomed Res Int       Date:  2017-09-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.